Investment funds have developed an interest in trading capital for royalties on drug commercializations
John Tamisiea, McDermott, Will & Emery
Advertisement
Articles by John Tamisiea, McDermott, Will & Emery
Advertisement
Latest Updated Articles
- Monetizing Intellectual Property: Royalties, Revenues and Alternative Sources of Capital
Published: April 10th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
One Connection, Endless Impact: Improving Patient Medication Access
2
Why Continuous Vendor Oversight Is Key to Healthcare Data Security
3
Optimizing Your CGT Commercial Distribution Strategy: Four Priorities for a Successful Launch
4
